News

Monday, 17 October 2011 - 11:27

The Treatment Action Campaign (TAC) has written a letter to the Council for Medical Schemes requesting for the designation of treatment for hepatitis B and C as prescribed minimum benefit conditions

The Treatment Action Campaign (TAC) has sent the letter below to the Council for Medical Schemes requesting for the designation of treatment for hepatitis B and C as prescribed minimum benefit conditions:

Introduction

  1. We are writing on behalf of the Treatment Action Campaign (TAC), a non-profit organisation that advocates for increased access...
Read more
Friday, 14 October 2011 - 15:57

Winstone Zulu, the first Zambian to live openly with HIV, a brave AIDS activist who rebelled against Thabo Mbeki's AIDS denialism and an outspoken proponent for the rights of people with HIV and TB, died on 12 October 2011.

He was a brave AIDS activist who rebelled against Thabo Mbeki's AIDS denialism

14 October 2011

Winstone Zulu, the first Zambian to live openly with HIV and an outspoken proponent for the rights of people with HIV and TB, died on 12 October 2011. The Treatment Action Group (not to be confused with us, the Treatment Action Campaign)...

Read more
Tuesday, 11 October 2011 - 00:00

On 7 October 2011 judgment was finally delivered for the nine men accused of murdering Zoliswa Nkonyana more than five years ago.  Four were found guilty, while the other five were released.  The case has been characterized by various failures of the criminal justice system in an area overburdened by crime.  Proceedings have been postponed more than forty times, suspects have escaped, evidence has been collected improperly, investigations...

Read more
Wednesday, 14 September 2011 - 00:00

For four years there was no clinic committee at Songonzima clinic near Elandskop in Kwazulu-Natal. As a result, serious service delivery problems at the clinic persisted. Then the Treatment Action Campaign’s (TAC) UMgungundlovu district office got involved – and now things are looking up.

 

For...

Read more
Tuesday, 13 September 2011 - 12:47

Exciting new evidence has demonstrated the potential of antiretroviral medicines (ARVs) to prevent HIV from being sexually transmitted. This TAC briefing explains the evidence and then discusses policy implications.


A TAC Briefing

 
Exciting new evidence has demonstrated the potential of antiretroviral medicines (ARVs) to prevent HIV from being sexually transmitted. This TAC briefing explains the evidence and then discusses policy implications.

 

 

Our recommendations...

Read more

Pages